Insider trading

Period: 120 months Stock: NUVB + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

62 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

62 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

62 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

62 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
62 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
62 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

62 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
19 Aug 2026
Hattersley Gary CHIEF SCIENTIFIC OFFICER
Sold on a plan
$709.24K 100,000 at 7.09
100%
Sold half or more
23 Jun 2026
Markel Stacy CHIEF PEOPLE OFFICER
Sold on a plan
$753.19K 125,000 at 6.03
79.3%
Sold half or more
23 Jun 2026
Wentworth Kerry CHIEF REGULATORY OFFICER
Sold on a plan
$379.19K 63,000 at 6.02
54.3%
Sold half or more
23 Jun 2026
Sauvage Philippe Chief Financial Officer
Sold on a plan
$286.37K 47,668 at 6.01
79.0%
Sold half or more
9 Jun 2026
Mashal Robert Director · indirect
Bought
$118.25K 25,000 at 4.73
12.5%
17 Apr 2026
Liu Dongfang CHIEF MEDICAL OFFICER
Sold on a plan
$251.00K 50,000 at 5.02
73.5%
Sold half or more
17 Apr 2026
Wentworth Kerry CHIEF REGULATORY OFFICER
Sold on a plan
$184.28K 36,750 at 5.01
40.9%
Planned (10b5-1)
6 Apr 2026
Wentworth Kerry CHIEF REGULATORY OFFICER
Sold on a plan
$903.56K 200,000 at 4.52
79.1%
Sold half or more
1 Dec 2025
Liu Dongfang CHIEF MEDICAL OFFICER
Sold at will
$1.17M 150,000 at 7.82
89.3%
Sold half or more
26 Nov 2025
Liu Dongfang CHIEF MEDICAL OFFICER
Sold at will
$80.00K 10,000 at 8.00
35.7%
Not planned
25 Nov 2025
Liu Dongfang CHIEF MEDICAL OFFICER
Sold at will
$75.00K 10,000 at 7.50
35.7%
Not planned
20 Nov 2025
Hattersley Gary CHIEF SCIENTIFIC OFFICER
Sold at will 2×
$2.67M 369,051 at 7.23
100%
Sold half or more
20 Nov 2025
Liu Dongfang CHIEF MEDICAL OFFICER
Sold at will
$140.07K 20,000 at 7.00
52.6%
Sold half or more
19 Nov 2025
Hanley David C. CHIEF TECHNICAL OPERATIONS
Sold at will
$1.43M 200,000 at 7.14
89.3%
Sold half or more
19 Nov 2025
Liu Dongfang CHIEF MEDICAL OFFICER
Sold at will
$76.55K 15,000 at 5.10
45.5%
Not planned
17 Nov 2025
Liu Dongfang CHIEF MEDICAL OFFICER
Sold at will
$71.48K 15,000 at 4.77
50.0%
Sold half or more
27 Oct 2025
Hattersley Gary CHIEF SCIENTIFIC OFFICER
Sold on a plan
$502.46K 100,000 at 5.02
100%
Sold half or more
18 Jun 2025
Markel Stacy CHIEF PEOPLE OFFICER
Bought
$17.10K 10,000 at 1.71
51.0%
First buy on file
17 Jun 2025
Sauvage Philippe Chief Financial Officer
Bought
$7.16K 4,000 at 1.79
67.8%
Largest buy in 3 yrs
16 Jun 2025
Hung David PRESIDENT AND CEO
Bought
$893.50K 500,000 at 1.79
0.9%
Largest buy in 3 yrs
16 Jun 2025
Sjogren Colleen Chief Commercial Officer
Bought
$90.35K 50,000 at 1.81
161%
First buy on file
16 Jun 2025
Wentworth Kerry CHIEF REGULATORY OFFICER
Bought 2×
$89.74K 50,000 at 1.79
opened
First buy on file
16 Jun 2025
Sauvage Philippe Chief Financial Officer
Bought
$6.06K 3,300 at 1.84
127%
First buy on file
2 May 2025
Liu Dongfang CHIEF MEDICAL OFFICER
Sold on a plan
$50.02K 20,000 at 2.50
62.5%
Sold half or more
7 Apr 2025
Hung David PRESIDENT AND CEO
Bought
$487.50K 300,000 at 1.63
0.5%
Largest buy in 3 yrs
4 Apr 2025
Hung David PRESIDENT AND CEO
Bought
$332.72K 200,000 at 1.66
0.3%
First buy on file
1 Apr 2025
Mashal Robert Director · indirect
Bought 2×
$166.99K 100,000 at 1.67
100%
+100% of stake
11 Nov 2024
Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD.
Sold at will
$162.88K 56,361 at 2.89
1.4%
Not planned
8 Oct 2024
Mashal Robert Director · indirect
Bought 2×
$220.00K 100,000 at 2.20
opened
First buy on file
25 Jun 2024
Cui Xiangmin Director · indirect
Bought
$825.35K 277,895 at 2.97
12.8%
24 Jun 2024
Cui Xiangmin Director · indirect
Bought
$1.00M 336,874 at 2.98
18.3%
Largest buy in 3 yrs
21 Jun 2024
Cui Xiangmin Director · indirect
Bought
$226.23K 75,411 at 3.00
4.3%
20 Jun 2024
Cui Xiangmin Director · indirect
Bought
$262.27K 87,715 at 2.99
5.2%
First buy on file
11 Jun 2024
BLICKENSTAFF KIM D Director · indirect
Bought
$500.09K 172,189 at 2.90
opened
First buy on file
21 Feb 2023
NODELMAN OLEG Director · indirect
Bought
$72.14K 53,000 at 1.36
0.4%
20 Feb 2023
NODELMAN OLEG Director · indirect
Bought
$159.49K 117,100 at 1.36
0.9%
19 Feb 2023
NODELMAN OLEG Director · indirect
Bought
$6.46M 5,143,000 at 1.26
69.9%
Largest buy in 3 yrs
5 Dec 2022
FALBERG KATHRYN E Director · indirect
Bought
$83.96K 43,000 at 1.95
20.8%
+21% of stake
2 Dec 2022
FALBERG KATHRYN E Director · indirect
Bought
$93.19K 47,000 at 1.98
29.4%
+29% of stake
1 Dec 2022
FALBERG KATHRYN E Director · indirect
Bought
$167.60K 84,959 at 1.97
113%
Largest buy in 3 yrs
30 Nov 2022
FALBERG KATHRYN E Director · indirect
Bought
$139.09K 75,041 at 1.85
opened
First buy on file
5 Apr 2022
Omega Fund V, L.P. 10% owner
Sold, plan not stated
$14.00M 2,500,000 at 5.60
10.9%
15 Dec 2021
Omega Fund V, L.P. 10% owner
Sold, plan not stated
$5.04M 500,000 at 10.07
2.1%
7 Dec 2021
Omega Fund V, L.P. 10% owner
Sold, plan not stated
$13.72M 1,400,000 at 9.80
5.6%
24 Nov 2021
NODELMAN OLEG Director · indirect
Bought 2×
$1.42M 185,026 at 7.69
2.6%
23 Nov 2021
Omega Fund V, L.P. 10% owner
Sold, plan not stated
$351.00 36 at 9.75
0.0%
22 Nov 2021
Omega Fund V, L.P. 10% owner
Sold, plan not stated
$2.88M 295,000 at 9.76
1.2%
3 Nov 2021
Omega Fund V, L.P. 10% owner
Sold, plan not stated
$18.50M 2,000,000 at 9.25
7.4%
29 Oct 2021
Omega Fund V, L.P. 10% owner
Sold, plan not stated
$417.15K 45,000 at 9.27
0.2%
28 Oct 2021
Omega Fund V, L.P. 10% owner
Sold, plan not stated
$9.74M 1,015,000 at 9.60
3.6%
Showing 1–50 of 62. Page 1 of 2 Older →